Detection and characterization of a type IIA secretory phospholipase A2 inhibitory protein in human amniotic fluid

Biol Pharm Bull. 2000 Oct;23(10):1163-6. doi: 10.1248/bpb.23.1163.

Abstract

Two types of phospholipase A2 (PLA2) inhibitory protein (PLIP-I, PLIP-II) were detected and isolated from human amniotic fluid by Sephacryl S300 gel filtration chromatography. The lower molecular weight-fraction (PLIP-II) was further purified by Sephadex G75 gel filtration and analyzed by SDS-PAGE. Its molecular weight was estimated to be approximately 18 kDa, and it was sensitive to heat treatment. Inhibition of phospholipase A2 (sPLA2 type IIA) by PLIP-II occurred in a dose-dependent manner (IC50 about 0.82/microm), and the effect was stronger on sPLA2 IIA than on pancreatic sPLA2 (IC50 about 3.11 microL). The ratio of the inhibitions of the sPLA2 IIA by PLIP-II remained consistent over an entire range of substrate concentrations. Furthermore, addition of excess Ca2+ at concentrations of up to 10 mm did not antagonize the inhibitory activity of PLIP-II.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Amniotic Fluid / chemistry*
  • Animals
  • Calcium / pharmacology
  • Chromatography, Ion Exchange
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Glycoproteins / analysis*
  • Glycoproteins / isolation & purification
  • Glycoproteins / pharmacology
  • Humans
  • Phosphodiesterase Inhibitors / analysis*
  • Phosphodiesterase Inhibitors / isolation & purification
  • Phosphodiesterase Inhibitors / pharmacology
  • Phospholipases A / antagonists & inhibitors*
  • Phospholipases A2
  • Pregnancy
  • Rabbits
  • Swine

Substances

  • Glycoproteins
  • Phosphodiesterase Inhibitors
  • phospholipase A2 inhibitory protein, Naja naja kaouthia
  • Phospholipases A
  • Phospholipases A2
  • Calcium